Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M.C. Chan, G.H. Lin (Taichung, Taiwan). Inhaled corticosteroid/long-acting beta-2 agonist (ICS/LABA) combination can decrease mortality of COPD patients, a nationwide population-based cohort study in Taiwan. Eur Respir J 2012; 40: Suppl. 56, 2114

Member's Comments

No comment yet.

Related content which might interest you: Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA) Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study Source: Eur Respir J, 53 (6) 1801257; 10.1183/13993003.01257-2018 Year: 2019 Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting ß2-agonist (ICS/LABA) in the UK Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 Inhaled corticosteroid therapy and risk of hospitalization with pneumonia: a population-based case-control study from Denmark Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Sub-optimal asthma control with medium- or high-dose ICS/LABA: a retrospective cohort study from Japan claims database Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016 Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018 Year: 2019 Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma Year: 2004 Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019 Year: 2020 Factors related to discontinuous use of inhaled drugs in COPD patients: A population-based cohort study in Lazio (Italy) Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012 Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients Source: Annual Congress 2004 - Primary care: asthma Year: 2004 Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Once-daily QVA149 demonstrates superior outcomes in COPD patients previously treated with fixed-dose long-acting beta2-agonist/inhaled corticosteroid (LABA/ICS): The ILLUMINATE study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009